Skip to main content

March 2015

 

 

academics

 

Clinical research courses

BREAKTHROUGHS IN EPIGENETICS

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Shashi Shekhar Anand, Navgeet, Balraj Singh Gill*
Centre for Biosciences,
School of Basic and Applied Sciences,
Central University of Punjab, Bathinda, India
gillsinghbalraj@gmail.com

ABSTRACT
The word ‘epigenetic’ was first coined by Conrad Waddington in 1946. It deals with functionally relevant modifications to the genome that do not include a change in the nucleotide sequence. Till date observation has focused on the functions of genome sequences and how their regulation occurs. The emerging epigenetic changes and the interactions between cis-acting elements with protein factors  plays a central role in gene regulation as well as give insight to various diseases. To evaluate the crosstalk of DNA and protein by taking account of the whole genome, one new evolving technique which is called as ChIP-chip, works on the principle of combining chromatin immunoprecipitation with microarray. ChIP-chip has been recently used in basic biological studies and may be improved further and can be useful for other to aspects, like human diseases. Now a days large amount of discoveries by ChIP-chip and other high-throughput techniques like this   may be connected with evolving bioinformatics to add to our knowledge of life and diseases.

Opportunity for Pharmacists (100 posts) to work in Apollo Pharmacy - Kolkata | B.Pharm/D.Pharm Only

Apollo pharmacy is a leading retail chain of pharmacy and is a unit of - Apollo Hospitals Enterprise Ltd. - Asia's largest healthcare group.
Our growing Retail Pharmacy network touches lives across the length and breadth of India and we serve 150000+ customers a day. With over 30 years of retailing experience, customer-focused service and brand value our network spans out to 1550+ retail pharmacies through which we have been serving our customers for their healthcare needs 24x7.

Post: Pharmacists

Walk in interview for Technical Officer, Laboratory technician in CSTM

Eligible candidates are invited to attend a WALK-IN-INTERVIEW on 02/04/2015 at 11 A.M. at Conference Room (4th, floor) School of Tropical Medicine. 108 Chittaranjan Avenue, Kolkata-73. for the following posts of NFUS 4 project (for 18 months only) on contractual basis funded by International Institute of Population Science, Ministry of Health and Family Welfare. Government of India.

Post: Technical Officer, Laboratory technician

Job as Technical Associate in Amrita University

Amrita University is a multi-campus, multi-disciplinary research university that is accredited 'A' by NAAC and is ranked as one of the best research universities in India. The university is spread across five campuses in three states of India - Kerala, Tamil Nadu and Karnataka, with the University headquarters at Ettimadai, Coimbatore, Tamil Nadu.

Vacancy as Trial Operations Specialist in Novartis

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post: Trial Operations Specialist

Career as Executive / Sr. Executive / Asst. Manager-SAP IT in Aspiring-Solutions hiring for its pharma client

We are hiring for our well reputed pharma client

Post: Executive / Sr. Executive / Asst. Manager-SAP IT (Mumbai & Mahad)

Application are invited for B.Pharm/ D.Pharm as Technical Assistant in NEIGRIHMS

NEIGRIHMS was established by the Government of India in 1987. It has been designed as a Postgraduate Medical Institute in lineage of AIIMS, New Delhi and PGIMER, Chandigarh. It is the First Postgraduate Medical Institute in the North Eastern Region and the Third in the Country established by Ministry of Health and Family Welfare, Government of India. The Institute was registered as a Society on 12th January 1987 by the Registrar of Societies, Meghalaya, Shillong under the name of - “North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences”

A STUDY ON DRUG UTILIZATION PATTERN AND EFFECTIVENESS OF ORAL HYPOGLYCEMIC AGENTS IN DIABETES MELLITUS

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Alti Aparna1*, Seema Pushpa Latha1, Gopalgari Lakshmi Nagarjun1, Galammagari Nagaraju1, C. Gopinath1, P. Murali Madhav2
1Annamacharya College of Pharmacy, Kadapa, Andhra Pradesh.
2Rajiv Gandhi Institute of Medical Science, Kadapa, Andhra Pradesh.
aparna.althi@gmail.com

ABSTRACT
Introduction: Diabetes mellitus is on alarming rise in India. Drug utilization studies help to identify the adherence to standard guidelines and extent of drug use and to evaluate the rational drug usage.
Aims and objectives: To determine the drug utilization pattern and effectiveness of oral hypoglycemic agents among diabetes mellitus patients.
Materials and methods: It is a prospective observational study carried out for a period of six months at RIMS kadapa, and two others diabetic centers. The diabetic patients who visited the medicine outpatient department were included. After obtaining approval from institutional ethical committee, a structured data collection form was used to collect demographic data, complete prescription details and other relevant information required for the study. The drug utilization pattern was determined. The drugs were categorized by Anatomical therapeutic classification (ATC) and DDD/1000 inhabitants/day was calculated by using WHO guidelines. Among all oral hypoglycemic agents the most effective drug/combination in this region was identified.
RESULTS:  716 prescriptions were assessed out of which,401(56.0%) were females and 315(43.9%) were males, most of the patients were in the age group of 40-60 for males 175(55%) and females 205(51.1%). Hypertension was the most common co-morbid seen. The average number of drugs per prescription was 4.26 and anti-diabetics per prescription was 1.79. DDD/1000 inhabitants/day for metformin (A10BA02) was 10.5, glimiperide (A10BB12) was 9.3, glibenclamide (A10BB01) was 7.91, pioglitazone (A10BG03) was 7.25. Out of 716 patients 311(45.25%) patients were on Monotherapy, and 405 (56.5%) were on Combination therapy.A total of 200 newly diagnosed patients of diabetes mellitus were enrolled in the study out of which only 128 members were followed up successfully. The combinations of Metformin +Sulfonyl Ureas + Others showed a good control of fasting blood sugar when compared with only Metformin, only Sulfonyl Ureas or Metformin +Sulfonyl Ureas, Sulfonyl Ureas + Others.
Conclusion: Metformin was the most utilized drug followed by glimiperide. Combination therapy was most frequent when compared to monotherapy in which metformin+glimiperide was commonly prescribed one. so by understanding  the current prescribing patterns attempts can be made to improve rational prescribing. The combination of Metformin+Sulfonyl Ureas+Others is more effective combination.

DEVELOPMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF LAMOTRIGINE AND CLOZAPINE IN SYNTHETIC MIXTURE BY ABSORPTION CORRECTION METHOD

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Priyanka P. Atodariya*, Hasumati A. Raj, Vineet C. Jain
*Shree Dhanvantary Pharmacy Collage, Kim,
Surat, Gujarat, India
*atodariya.priyanka@yahoo.com

ABSTRACT:
The simple spectroscopic method has been developed for simultaneous estimation of Lamotrigine and Clozapine in synthetic mixture. Absorbance Correction Method involves the measurement of absorption at two wavelengths 307 nm (lmaxfor Lamotrigine) and 360 nm (lmax for Clozapine). The method was found linear between the range of 1-5 µg/ml for Lamotrigine and 6-30 µg/ml for Clozapine for method. The accuracy and precision was determined and validated statistically. Both the method showed good reproducibility and recovery with %RSD less than 1. The method was found to be rapid, specific, precise and accurate and can be successfully applied for the routine analysis for Lamotrigine and Clozapine in bulk and combined dosage form.

ANTICONVULSANT EFFECT OF LEAF AND BARK OF ERYTHRINA VARIEGATA LINN AND BUTEA MONOSPERMA (LAM) TAUB IN DIFFERENT EXPERIMENTAL CONVULSION MODEL IN RATS

ABOUT AUTHORS:
Prakash T. Sangale*1, Dhananjay B. Deshmukh2, Rajesh Bhambere3
1Department of Quality Assurance Techniques,
2Department of Pharmacology,
VJSM’S Vishal Institute of Pharmaceutical Education and Research,
Ale, Junnar, Pune
*prakashsangale091@gmail.com

{ DOWNLOAD AS PDF }

ABSTRACT
Epilepsy is a chronic disorder characterized by the occurrence of epileptic seizures, with or without characteristic body movements (convulsion)affecting about 50 million people worldwide. Synthetic drugs for the treatment of epilepsy are associated with severe side effects and addiction liabilities upon long term uses. Thus, researchers around the globe are searching for natural resources.Erythrinavariegata and Butea monosperma is a traditional medicinal plant used to treat a seizure.The present studies reveal that the anticonvulsant activity by Erythrina variegate & Butea monosperma of bark & leaf PTZ and MES induced convulsions in wistar rats using Erythrina variegata & Butea monosperma of bark & leaf ethanolic extracts extracted successively. However, the anticonvulsant activity of this plant has not been studied in depth.

In Pentylene tetrazole (PTZ) an maximal electro shock seizure(MES) models test parameters like latncy, onset of tonic convulsions, clonic convulsions and percent protection were observed in the different test groups. Inconclusion, we showed that the ethanolic extract of Erythrina variegata and Butea monosperma has anticonvulsant effect in the both models, suggesting their possible depressant action in the central nervous system. EEBM and EEEV gave significant protection (P<0.001) against PTZ & MES induce convulsion.